Shire Vyvanse 30mg Capsules Recall: Foreign Tablets Found
Shire recalls Vyvanse 30mg capsules due to foreign tablets detected. Affected units: 100-count bottles with NDC 59417-103-1: Lot AF3360B, expiring April 2019.
Lower-risk recall
Presence of Foreign Tablets/Capsules
Contact the company
What happened, in plain English
Shire is recalling Vyvanse 30mg capsules because foreign tablets were found in some batches. This could cause harm if taken by mistake. People with prescriptions should check their bottle details and contact Shire if unsure. Read more at govinfonow.com/recall/42454-shire-vyvanse-30mg-capsules-recall-foreign-tablets-found.
Source Summary by GovInfoNow · govinfonow.com/recall/42454-shire-vyvanse-30mg-capsules-recall-foreign-tablets-found · Updated October 9, 2026 · FDA enforcement record: FDA #D-0006-2017
Cite this page
“Shire Vyvanse 30mg Capsules Recall: Foreign Tablets Found.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42454-shire-vyvanse-30mg-capsules-recall-foreign-tablets-found. Based on FDA recall #D-0006-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0006-2017%22&limit=1).
Why it’s dangerous
Foreign tablets were found in some batches of Vyvanse capsules. If accidentally taken, these could cause harm. The hazard is not described as causing serious injury in normal use.
Who’s affected
Prescription users of Vyvanse 30mg capsules with NDC 59417-103-10, Lot AF3360B, expiring April 2019. Those who have the specific bottle details are most at risk.
How to tell if you have this one
Check for NDC 59417-103-10, Lot AF3360B, and expiration date April 2019 on the bottle. The product is prescription-only and requires a doctor's order.
- Brand
Shire- Category
Drug
What to do — step by step
Check Bottle Details
Look for NDC 59417-103-10, Lot AF3360B, and expiration date April 2019 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.5 years after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0006-2017 (September 2, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0006-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.